Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Linking Persons With HIV, Discharged From Jail, With Community Care

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Diagnostic Test: Point-of-Care (POC) Rapid HIV Test
Diagnostic Test: Fourth Generation Antigen/antibody (Ag/Ab) HIV Test

First Posted Date: 2020-09-23

Last Posted Date: 2022-05-23

Lead Sponsor: Emory University

Target Recruit Count: 122

Registration Number: NCT04560556

Locations: 🇺🇸
DC Department of Corrections, Washington, District of Columbia, United States

Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders

Phase 3

Completed

Conditions: Substance Withdrawal
Substance-Related Disorders
Substance Use Disorders
Opioid-use Disorder
Opioid Use Disorder, Severe
Substance Abuse, Intravenous
Substance Abuse
Opioid Use

Interventions: Device: Non invasive VN stimulation (nVNS)
Device: Sham Stimulation
Drug: Oxygen (15-O) Water

First Posted Date: 2020-09-21

Last Posted Date: 2023-09-13

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT04556552

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

NOninVasive Intracranial PrEssure from Transcranial DoppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients

Recruiting

Conditions: Subarachnoid Hemorrhage
Ischemic Stroke
Intracerebral Hemorrhage
Liver Failure
Traumatic Brain Injury

First Posted Date: 2020-09-14

Last Posted Date: 2024-12-18

Lead Sponsor: Emory University

Target Recruit Count: 432

Registration Number: NCT04548596

Locations: 🇺🇸
UC Davis, Davis, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 1 locations

Efficacy of a Smoke-Free Homes Intervention

Not Applicable

Active, not recruiting

Conditions: Cessation, Smoking

Interventions: Behavioral: Smoke-Free Homes Intervention
Behavioral: Control

First Posted Date: 2020-09-14

Last Posted Date: 2024-12-27

Lead Sponsor: Emory University

Target Recruit Count: 918

Registration Number: NCT04547686

Locations: 🇺🇸
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States

Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

Completed

Conditions: HIV Prevention

Interventions: Drug: Estrogen
Drug: Estrogen plus Progesterone

First Posted Date: 2020-08-31

Last Posted Date: 2025-06-17

Lead Sponsor: Emory University

Target Recruit Count: 285

Registration Number: NCT04531943

Locations: 🇺🇸
Hope Clinic, Atlanta, Georgia, United States

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Phase 2

Active, not recruiting

Conditions: Advanced Pancreatic Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Stage IV Pancreatic Cancer AJCC v8

Interventions: Drug: Gemcitabine
Drug: Hydroxychloroquine
Drug: Nab-paclitaxel
Drug: Paricalcitol

First Posted Date: 2020-08-24

Last Posted Date: 2024-01-11

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT04524702

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hosptial, Atlanta, Georgia, United States

Spironolactone Safety in African Americans with Mild Cognitive Impairment and Early Dementia

Phase 4

Active, not recruiting

Conditions: Mild Cognitive Impairment
Alzheimer Disease

Interventions: Drug: Spironolactone
Drug: Placebo

First Posted Date: 2020-08-21

Last Posted Date: 2024-10-15

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT04522739

Locations: 🇺🇸
Emory Clinic at Executive Park, Atlanta, Georgia, United States

Childhood Cancer Predisposition Study (CCPS)

Recruiting

Conditions: Pediatric Cancer

Interventions: Other: Registry

First Posted Date: 2020-08-13

Last Posted Date: 2024-10-07

Lead Sponsor: Emory University

Target Recruit Count: 1050

Registration Number: NCT04511806

Locations: 🇺🇸
Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 4 locations

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Phase 2

Terminated

Conditions: Non-small Cell Lung Cancer
Renal Cell Carcinoma

Interventions: Drug: Preoperative Ketorolac

First Posted Date: 2020-08-03

Last Posted Date: 2025-03-04

Lead Sponsor: Emory University

Target Recruit Count: 68

Registration Number: NCT04495894

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory Clinic, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

and more 1 locations

Bacteriostatic Normal Saline Versus Lidocaine for Intradermal Anesthesia

Phase 4

Completed

Conditions: Chronic Pain

Interventions: Drug: Bacteriostatic Normal Saline
Drug: 1% Lidocaine

First Posted Date: 2020-08-03

Last Posted Date: 2023-04-18

Lead Sponsor: Emory University

Target Recruit Count: 40

Registration Number: NCT04495868

Locations: 🇺🇸
Grady Pain Clinic, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy